{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T04:10:10Z","timestamp":1748405410389,"version":"3.41.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T00:00:00Z","timestamp":1748390400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T00:00:00Z","timestamp":1748390400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Contracept Reprod Med"],"DOI":"10.1186\/s40834-025-00371-6","type":"journal-article","created":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T03:43:43Z","timestamp":1748403823000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Long-acting reversible contraception initiation after medication abortion: a retrospective cohort study"],"prefix":"10.1186","volume":"10","author":[{"given":"Summer L.","family":"Martins","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jill","family":"Miller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Madeline","family":"Mahoney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katelyn M.","family":"Tessier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah A.","family":"Traxler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christy M.","family":"Boraas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,5,28]]},"reference":[{"key":"371_CR1","volume-title":"Medication abortion now accounts for more than half of all US abortions. Policy analysis","author":"R Jones","year":"2022","unstructured":"Jones R, Nash E, Cross L, Philbin J, Kirstein M. Medication abortion now accounts for more than half of all US abortions. Policy analysis. New York: Guttmacher Institute; 2022."},{"key":"371_CR2","doi-asserted-by":"publisher","first-page":"e91","DOI":"10.1097\/AOG.0000000000004475","volume":"138","author":"Access to Postabortion Contraception","year":"2021","unstructured":"Access to Postabortion Contraception. ACOG committee opinion, number 833. Obstet Gynecol. 2021;138:e91\u20135. https:\/\/doi.org\/10.1097\/AOG.0000000000004475","journal-title":"Obstet Gynecol"},{"key":"371_CR3","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1097\/AOG.0000000000001274","volume":"127","author":"EG Raymond","year":"2016","unstructured":"Raymond EG, Weaver MA, Tan YL, Louie KS, Bousi\u00e9guez M, Lugo-Hern\u00e1ndez EM, et al. Effect of immediate compared with delayed insertion of etonogestrel implants on medical abortion efficacy and repeat pregnancy: a randomized controlled trial. Obstet Gynecol. 2016;127:306\u201312. https:\/\/doi.org\/10.1097\/AOG.0000000000001274","journal-title":"Obstet Gynecol"},{"key":"371_CR4","doi-asserted-by":"publisher","first-page":"2484","DOI":"10.1093\/humrep\/dew238","volume":"31","author":"H Hognert","year":"2016","unstructured":"Hognert H, Kallner HK, Cameron S, Nyrelli C, Jawad I, Heller R, et al. Immediate versus delayed insertion of an etonogestrel releasing implant at medical abortion-a randomized controlled equivalence trial. Hum Reprod. 2016;31:2484\u201390. https:\/\/doi.org\/10.1093\/humrep\/dew238","journal-title":"Hum Reprod"},{"key":"371_CR5","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.contraception.2020.08.004","volume":"102","author":"Practice Bulletins\u2014Gynecology, the Society of Family Planning","year":"2020","unstructured":"Practice Bulletins\u2014Gynecology, the Society of Family Planning. Medication abortion up to 70 days of gestation. Contraception. 2020;102:225\u201336. https:\/\/doi.org\/10.1016\/j.contraception.2020.08.004","journal-title":"Contraception"},{"key":"371_CR6","doi-asserted-by":"publisher","first-page":"100049","DOI":"10.1016\/j.conx.2020.100049","volume":"2","author":"UD Upadhyay","year":"2020","unstructured":"Upadhyay UD, Schroeder R, Roberts SCM. Adoption of no-test and telehealth medication abortion care among independent abortion providers in response to COVID-19. Contracept X. 2020;2:100049. https:\/\/doi.org\/10.1016\/j.conx.2020.100049","journal-title":"Contracept X"},{"key":"371_CR7","doi-asserted-by":"publisher","first-page":"e1071","DOI":"10.1016\/j.ajog.2017.09.020","volume":"218","author":"CH Rocca","year":"2018","unstructured":"Rocca CH, Goodman S, Grossman D, Cadwallader K, Thompson KMJ, Talmont E, et al. Contraception after medication abortion in the United States: results from a cluster randomized trial. Am J Obstet Gynecol. 2018;218:e1071\u20138. https:\/\/doi.org\/10.1016\/j.ajog.2017.09.020","journal-title":"Am J Obstet Gynecol"},{"key":"371_CR8","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.contraception.2019.05.001","volume":"100","author":"AH Roe","year":"2019","unstructured":"Roe AH, Fortin J, Janiak E, Maurer R, Goldberg AB. Prevalence and predictors of initiation of intrauterine devices and subdermal implants immediately after surgical abortion. Contraception. 2019;100:89\u201395. https:\/\/doi.org\/10.1016\/j.contraception.2019.05.001","journal-title":"Contraception"},{"key":"371_CR9","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","volume":"42","author":"PA Harris","year":"2009","unstructured":"Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inf. 2009;42:377\u201381. https:\/\/doi.org\/10.1016\/j.jbi.2008.08.010","journal-title":"J Biomed Inf"},{"key":"371_CR10","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1080\/17441692.2016.1174280","volume":"13","author":"J Benson","year":"2018","unstructured":"Benson J, Andersen K, Brahmi D, et al. What contraception do women use after abortion? An analysis of 319,385 cases from eight countries. Glob Public Health. 2018;13:35\u201350. https:\/\/doi.org\/10.1080\/17441692.2016.1174280","journal-title":"Glob Public Health"},{"key":"371_CR11","doi-asserted-by":"publisher","first-page":"2208","DOI":"10.1056\/NEJMoa1011600","volume":"364","author":"PH Bednarek","year":"2011","unstructured":"Bednarek PH, Creinin MD, Reeves MF, Cwiak C, Espey E, Jensen JT. Immediate versus delayed IUD insertion after uterine aspiration. N Engl J Med. 2011;364:2208\u201317. https:\/\/doi.org\/10.1056\/NEJMoa1011600","journal-title":"N Engl J Med"},{"key":"371_CR12","doi-asserted-by":"publisher","first-page":"412","DOI":"10.5694\/mja14.00011","volume":"201","author":"P Goldstone","year":"2014","unstructured":"Goldstone P, Mehta YH, McGeechan K, Francis K, Black KI. Factors predicting uptake of long-acting reversible methods of contraception among women presenting for abortion. Med J Aust. 2014;201:412\u20136. https:\/\/doi.org\/10.5694\/mja14.00011","journal-title":"Med J Aust"},{"key":"371_CR13","unstructured":"Minnesota Department of Human Services. Minnesota Family Planning Program. https:\/\/mn.gov\/\/dhs\/people-we-serve\/children-and-families\/health-care\/health-care-programs\/programs-and-services\/family-planning.jsp. Accessed 19 December 2022."},{"key":"371_CR14","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.contraception.2013.10.014","volume":"89","author":"AM Langston","year":"2014","unstructured":"Langston AM, Joslin-Roher SL, Westhoff CL. Immediate postabortion access to IUDs, implants and DMPA reduces repeat pregnancy within 1 year in a New York City practice. Contraception. 2014;89:103\u20138. https:\/\/doi.org\/10.1016\/j.contraception.2013.10.014","journal-title":"Contraception"},{"key":"371_CR15","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.contraception.2008.09.003","volume":"79","author":"AM Stanek","year":"2009","unstructured":"Stanek AM, Bednarek PH, Nichols MD, Jensen JT, Edelman AB. Barriers associated with the failure to return for intrauterine device insertion following first-trimester abortion. Contraception. 2009;79:216\u201320. https:\/\/doi.org\/10.1016\/j.contraception.2008.09.003","journal-title":"Contraception"},{"key":"371_CR16","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/j.contraception.2018.06.001","volume":"98","author":"NZ Fang","year":"2018","unstructured":"Fang NZ, Sheeder J, Teal SB. Factors associated with initiating long-acting reversible contraception immediately after first-trimester abortion. Contraception. 2018;98:292\u20135. https:\/\/doi.org\/10.1016\/j.contraception.2018.06.001","journal-title":"Contraception"},{"key":"371_CR17","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1097\/AOG.0000000000002361","volume":"130","author":"MA Biggs","year":"2017","unstructured":"Biggs MA, Taylor D, Upadhyay UD. Role of insurance coverage in contraceptive use after abortion. Obstet Gynecol. 2017;130:1338\u201346. https:\/\/doi.org\/10.1097\/AOG.0000000000002361","journal-title":"Obstet Gynecol"},{"key":"371_CR18","doi-asserted-by":"publisher","first-page":"e7161","DOI":"10.1016\/j.ajog.2015.12.009","volume":"214","author":"CH Rocca","year":"2016","unstructured":"Rocca CH, Thompson KM, Goodman S, Westhoff CL, Harper CC. Funding policies and postabortion long-acting reversible contraception: results from a cluster randomized trial. Am J Obstet Gynecol. 2016;214:e7161\u20138. https:\/\/doi.org\/10.1016\/j.ajog.2015.12.009","journal-title":"Am J Obstet Gynecol"},{"key":"371_CR19","doi-asserted-by":"publisher","first-page":"e173","DOI":"10.1016\/j.whi.2013.03.001","volume":"23","author":"RK Jones","year":"2013","unstructured":"Jones RK, Upadhyay UD, Weitz TA. At what cost? Payment for abortion care by U.S. Women. Womens Health Issues. 2013;23:e173\u20138. https:\/\/doi.org\/10.1016\/j.whi.2013.03.001","journal-title":"Womens Health Issues"},{"key":"371_CR20","first-page":"1","volume":"24","author":"AA Sonfield","year":"2021","unstructured":"Sonfield AA, Fragmented System. Ensuring comprehensive contraceptive coverage in all U.S. Health insurance plans. Guttmacher Policy Rev. 2021;24:1\u20137.","journal-title":"Guttmacher Policy Rev"},{"key":"371_CR21","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/j.contraception.2011.09.007","volume":"85","author":"EL Horning","year":"2012","unstructured":"Horning EL, Chen BA, Meyn LA, Creinin MD. Comparison of medical abortion follow-up with serum human chorionic gonadotropin testing and in-office assessment. Contraception. 2012;85:402\u20137. https:\/\/doi.org\/10.1016\/j.contraception.2011.09.007","journal-title":"Contraception"}],"container-title":["Contraception and Reproductive Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40834-025-00371-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40834-025-00371-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40834-025-00371-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T03:43:47Z","timestamp":1748403827000},"score":1,"resource":{"primary":{"URL":"https:\/\/contraceptionmedicine.biomedcentral.com\/articles\/10.1186\/s40834-025-00371-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,28]]},"references-count":21,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["371"],"URL":"https:\/\/doi.org\/10.1186\/s40834-025-00371-6","relation":{},"ISSN":["2055-7426"],"issn-type":[{"value":"2055-7426","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,28]]},"assertion":[{"value":"12 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study protocol was approved by the University of Minnesota Institutional Review Board, which deemed the study to be of minimal risk and thus waived the requirement of informed consent. All methods were carried out in accordance with relevant guidelines and regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Presented at the American College of Obstetricians and Gynecologists Annual Clinical and Scientific Meeting, April 30-May 2, 2021.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Previous presentations"}}],"article-number":"34"}}